8% NVN1000 Topical Gel

DRUG2 trials

Sponsors

Novan, Inc.

Conditions

Acne Vulgaris

Phase 1

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

CompletedNCT01694810

Novan, Inc.Acne Vulgaris

Start: 2012-09-30End: 2012-11-30Updated: 2020-01-30

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

CompletedNCT01755247

Novan, Inc.Acne Vulgaris

Start: 2012-11-30End: 2012-12-31Updated: 2019-09-10